Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its flagship oncology therapy.Check out the current price of CTXR stock here. LYMPHIR Launch Marks First... Read more
Benzinga - Dec 24